The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
We focus on a number of topic areas identified by state health policy leaders as important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to population health.
Feb 2, 2015 | Christopher F. Koller, President
Improving population health by building more and better primary care in the United States might be considered an exercise in what a nun I once met called, “the theology of the long haul.” I am not sure we have God on our side here, but we do have evidence—much of it published in The Milbank Quarterly by research titans like Barbara Starfield. The evidence is clear—the foundation of any high … Read more
Jan 28, 2015 | Christopher F. Koller, President
“Don’t try to teach a pig to sing, Chris,” a colleague once advised me, quoting the well-known saying. “You won’t succeed and you will only tick off the pig.” The image of singing swine seems particularly apt right now as we look at the question of whether medical providers can practice “population health.” A recent op-ed in The Milbank Quarterly and presentations about community health and … Read more
Dec 19, 2014 | Christopher F. Koller, President
Put a bunch of state leaders in a room, kick out the hangers-on, close the door, and ask them where they need help in health policy. What do they say? This is not a hypothetical question. The Milbank Memorial Fund did just that for three weeks in a row last month. And the responses were illuminating. The occasion was the fall meetings of the Fund’s Reforming States Group (RSG), a group with a … Read more
Nov 25, 2014 | Christopher F. Koller, President
For state leaders, Ebola has been a “Pac-Man” issue—inexorably gobbling up resources and time and, like the disease itself, constantly threatening to break out of control. The public health response to the outbreak of a new and life-threatening infectious disease is complex; it involves unclear authority, necessitates changing policy responses, and guarantees lots of media attention. All in … Read more
Oct 16, 2014 | Christopher F. Koller, President
What kind of coverage decisions are states making about Sovaldi, the new Hepatitis C drug that costs $1,000 a pill or up to $168,000 a treatment? The drug presents new hope for patients, but grave risks to Medicaid and state corrections budgets, both of which must pay for care for a disproportionate number of people with Hepatitis C. Drugs like Sovaldi—and there are more like it on the … Read more
Sep 1, 2014 | Christopher F. Koller, President
How does systemic restructuring happen in health care delivery systems? It’s a given among the health policy intelligentsia that to improve the value of health care in the United States, delivery systems need to “restructure”—to change the people, technology, and processes used to provide medical care. The conventional wisdom is that this restructuring is an even bigger policy challenge than … Read more
Aug 1, 2014 | Christopher F. Koller, President
“Physicians at my hospital are retiring. Younger doctors are exploring opportunities in other regions where they can make more money. I can’t recruit new physicians. If my rates from payers don’t improve, I won’t have any providers to see patients.” When I was Health Insurance Commissioner in Rhode Island reviewing proposed rate increases from insurers, I regularly heard complaints like these. … Read more
Jul 1, 2014 | Christopher F. Koller, President
Every once in a while, an issue comes along that serves up so clearly the conflict between a societal desire to maximize medical care treatment choices and the reality of limited resources that people say, “Maybe this is the one that will provoke the hard conversations.” Enter Sovaldi for the treatment of Hepatitis C. In the US, about 2.7 to 5.2 million people have Hepatitis C, a chronic … Read more
Jun 1, 2014 | Christopher F. Koller, President
“Knowing is not enough; we must apply. Willing is not enough; we must do.” These words of the German poet Goethe grace each final report of the Institute of Medicine (IOM) of the National Academy of Sciences in Washington, DC—and are meant to inspire or compel readers to link theory and practice, thinking and doing. The IOM exists to “…help those in government and the private sector … Read more
May 1, 2014 | Christopher F. Koller, President
I recently addressed a gathering of about 50 health leaders—providers, payers and state officials—who had come together at a Milbank Memorial Fund-convened meeting as part of their work on implementing local multi-payer primary care enhancement projects. This is just the kind of work the Fund likes to support—improving population health by linking leaders and decision makers with the best … Read more
by Christopher Koller | President, Milbank Memorial Fund
Read blogs published by guest authors.
The Milbank Memorial Fund is an endowed operating foundation that works to improve the health of populations by connecting leaders and decision makers with the best available evidence and experience.